Skip to main content
Article
Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing (3V): Real-world data from large midwestern healthcare system
Journal of Clinical Oncology
  • Sigrun Hallmeyer, Advocate Aurora Health
  • Michael A Thompson, Advocate Aurora Health
  • Veronica Fitzpatrick, Advocate Aurora Health
  • Yunqi Liao, Advocate Aurora Health
  • Michael P Mullane, Advocate Aurora Health
  • Stephen Medlin, Advocate Aurora Health
  • Katherine Cleland, Advocate Aurora Health
  • Tulio E Rodriguez, Advocate Aurora Health
  • Robert Citronberg, Advocate Aurora Health
  • James Weese, Advocate Aurora Health
Affiliations

Aurora Cancer Care, Advocate Aurora Health

Advocate Aurora Health

Aurora Cancer Care

Advocate Lutheran General Hospital

Scholarly Activity Date
1-1-2022
Type
Abstract
Citation Information

Hallmeyer S, Thompson MA, Fitzpatrick V, et al. Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing (3V): Real-world data from large midwestern healthcare system. Journal of Clinical Oncology. 2022;40(16_suppl):e19513.